ÿþ<HTML><HEAD><TITLE>25º Congresso Brasileiro de Microbiologia </TITLE><link rel=STYLESHEET type=text/css href=css.css></HEAD><BODY aLink=#ff0000 bgColor=#FFFFFF leftMargin=0 link=#000000 text=#000000 topMargin=0 vLink=#000000 marginheight=0 marginwidth=0><table align=center width=700 cellpadding=0 cellspacing=0><tr><td align=left bgcolor=#cccccc valign=top width=550><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=3><font size=1>25º Congresso Brasileiro de Microbiologia </font></font></strong><font face=Verdana size=1><b><br></b></font><font face=Verdana, Arial,Helvetica, sans-serif size=1><strong> </strong></font></font></td><td align=right bgcolor=#cccccc valign=top width=150><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=1><font size=1>ResumoID:1851-2</font></em></font></strong></font></td></tr><tr><td colspan=2><br><br><table align=center width=700><tr><td>Área: <b>Fermentação e Biotecnologia ( Divisão J )</b><p align=justify><strong> <DIV STYLE="TEXT-ALIGN: CENTER; FONT-WEIGHT: BOLD;">EFFECT OF CULTURE CONDITIONS ON RECOMBINANT ASPARAGINASE PRODUCTION IN <SPAN STYLE="FONT-STYLE: ITALIC;">ESCHERICHIA COLI</SPAN> </DIV> </strong></p><p align=justify><b>Gustavo Roth </b> (<i>INCT-TB PUCRS</i>); <b><u>Priscila Lamb Wink </u></b> (<i>INCT-TB PUCRS</i>); <b>Christiano Ev Neves </b> (<i>INCT-TB PUCRS</i>); <b>Natasha Kuniechick </b> (<i>INCT-TB PUCRS</i>); <b>Rafael Munareto do Nascimento </b> (<i>INCT-TB PUCRS</i>); <b>Giandra Volpato </b> (<i>Quatro G</i>); <b>Gaby Renard </b> (<i>Quatro G</i>); <b>Jocelei Maria Chies </b> (<i>Quatro G</i>); <b>Luiz Augusto Basso </b> (<i>INCT-TB PUCRS</i>); <b>Diógenes Santiago Santos </b> (<i>INCT-TB PUCRS</i>)<br><br></p><b><font size=2>Resumo</font></b><p align=justify class=tres><font size=2> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-size: 12pt; line-height: 150%; font-style: italic;" lang="EN-US">Mycobacterium tuberculosis</span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">, the agent of human tuberculosis (TB), causes about 2 million deaths per year. It is estimated by the World Health Organization that one-third of the world s population is infected with <span style="font-style: italic;">M. tuberculosis</span> in a latent form. Furthermore, the increasing emergence of multidrug-resistant strains has complicated the treatment and control of TB. Knowledge of the mode of action and role of purine <i style="">de novo</i> pathway enzymes in <span style="font-style: italic;">M. tuberculosis</span>, which are required for mycobacterial growth, could reveal new targets for the rational design of potent and selective </span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">anti-TB </span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">agents that might be active against drug-resistant strains. Inosine monophosphate dehydrogenase (IMPDH) catalyzes the nicotinamide-adenine dinucleotide (NAD<sup>+</sup>)-dependent oxidation of inosine 5 -monophosphate (IMP) to xanthosine 5 -monophosphate (XMP). </span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">Because this enzyme acts on the synthesis of purine nucleotides at a critical step, it can be essential for mycobacterial growth</span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">. </span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">The goal of this work </span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">is to study and understand the kinetics and biochemistry of the recombinant IMPDH enzyme from <i style="">M. tuberculosis</i>. </span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">The complete DNA coding sequence of IMPDH (EC 1.1.1.205) from <i style="">M. tuberculosis</i> was obtained using genomic DNA in standard polymerase chain reaction (PCR) conditions. The amplified fragment was cloned into the pCR-Blunt vector and subcloned into the <i><span style="">&nbsp;</span>Nde</i>I/<i>Hin</i>dIII polylinker region of the pET-23a (+) prokaryotic expression vector. </span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">Nucleotide sequence of the cloned fragment was determined by automated DNA sequencing. The recombinant plasmid was then subjected to different expression tests in different <span style="font-style: italic;">Escherichia coli</span> strains. The enzyme was expressed in E. coli BL21 (DE3) cells in the soluble fraction, providing sufficient material for purification by FPLC, biochemistry assays, determination of its three-dimensional structure and study of its key enzymological properties.</span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US"> These results have important implications for understanding the purine metabolism of the TB bacillus and </span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US">will serve as an initial step toward the future rational design of specific inhibitors and drugs for this <span style="font-style: italic;">M. tuberculosis</span> enzyme.</span><span style="font-size: 12pt; line-height: 150%;" lang="EN-US"><o:p></o:p></span></p> </font></p><br><b>Palavras-chave: </b>&nbsp;Asparaginase, Culture conditions, Erwinia carotovora, Plackett Burman design</td></tr></table></tr></td></table></body></html>